ArticleHealth science reports2024
Depression and related factors among patients with post-COVID-19 conditions: Cross-sectional, hospital-based study.
Article in Health science reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Depression and related factors among patients with post-COVID-19 conditions: Cross-sectional, hospital-based study.Health science reports · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: The COVID-19 crisis has significantly impacted public health, particularly mental health. This study aims to determine the prevalence of depression and related factors among patients with post-COVID-19 conditions in an outpatient clinic at a tertiary referral hospital in Southern Vietnam. Methods: A cross-sectional survey was conducted among 410 patients with post-COVID-19 conditions in an outpatient clinic at the University Medical Center Ho Chi Minh City. A convenience sampling method was used to screen for depression using the Patient Health Questionnaire-9 (PHQ-9). Results: A total of 410 patients participated in the study. Depression was observed in 23.7% of respondents, categorized as mild (80.4%), moderate (16.5%), or severe (3.1%) based on PHQ-9 scores. Factors influencing depression included age 50 years or older, religion, education level, full-time employment, marital status, family contact, use of anti-inflammatory drugs, hospital admission due to COVID-19, chronic diseases, hypertension, and post-COVID-19 symptoms (shortness of breath, palpitations, fatigue, headache, abdominal pain, brain fog, insomnia, and loss of appetite). The most common symptoms reported were cough, dyspnea, shortness of breath, fatigue, and loss of appetite. A Conclusion: The prevalence of depression among patients with post-COVID-19 conditions in the outpatient clinic was high. Improving mental health and quality of life, alongside the prevention and treatment of COVID-19, should remain public health priorities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.